Cargando…

Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension

The renin–angiotensin–aldosterone system (RAAS) impacts cardiovascular homeostasis via direct actions on peripheral blood vessels and via modulation of the autonomic nervous system. To date, research has primarily focused on the actions of the RAAS on the sympathetic nervous system. Here, we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanks, Julia, Ramchandra, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624735/
https://www.ncbi.nlm.nih.gov/pubmed/34830184
http://dx.doi.org/10.3390/ijms222212305
_version_ 1784606246974783488
author Shanks, Julia
Ramchandra, Rohit
author_facet Shanks, Julia
Ramchandra, Rohit
author_sort Shanks, Julia
collection PubMed
description The renin–angiotensin–aldosterone system (RAAS) impacts cardiovascular homeostasis via direct actions on peripheral blood vessels and via modulation of the autonomic nervous system. To date, research has primarily focused on the actions of the RAAS on the sympathetic nervous system. Here, we review the critical role of the RAAS on parasympathetic nerve function during normal physiology and its role in cardiovascular disease, focusing on hypertension. Angiotensin (Ang) II receptors are present throughout the parasympathetic nerves and can modulate vagal activity via actions at the level of the nerve endings as well as via the circumventricular organs and as a neuromodulator acting within brain regions. There is tonic inhibition of cardiac vagal tone by endogenous Ang II. We review the actions of Ang II via peripheral nerve endings as well as via central actions on brain regions. We review the evidence that Ang II modulates arterial baroreflex function and examine the pathways via which Ang II can modulate baroreflex control of cardiac vagal drive. Although there is evidence that Ang II can modulate parasympathetic activity and has the potential to contribute to impaired baseline levels and impaired baroreflex control during hypertension, the exact central regions where Ang II acts need further investigation. The beneficial actions of angiotensin receptor blockers in hypertension may be mediated in part via actions on the parasympathetic nervous system. We highlight important unknown questions about the interaction between the RAAS and the parasympathetic nervous system and conclude that this remains an important area where future research is needed.
format Online
Article
Text
id pubmed-8624735
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86247352021-11-27 Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension Shanks, Julia Ramchandra, Rohit Int J Mol Sci Review The renin–angiotensin–aldosterone system (RAAS) impacts cardiovascular homeostasis via direct actions on peripheral blood vessels and via modulation of the autonomic nervous system. To date, research has primarily focused on the actions of the RAAS on the sympathetic nervous system. Here, we review the critical role of the RAAS on parasympathetic nerve function during normal physiology and its role in cardiovascular disease, focusing on hypertension. Angiotensin (Ang) II receptors are present throughout the parasympathetic nerves and can modulate vagal activity via actions at the level of the nerve endings as well as via the circumventricular organs and as a neuromodulator acting within brain regions. There is tonic inhibition of cardiac vagal tone by endogenous Ang II. We review the actions of Ang II via peripheral nerve endings as well as via central actions on brain regions. We review the evidence that Ang II modulates arterial baroreflex function and examine the pathways via which Ang II can modulate baroreflex control of cardiac vagal drive. Although there is evidence that Ang II can modulate parasympathetic activity and has the potential to contribute to impaired baseline levels and impaired baroreflex control during hypertension, the exact central regions where Ang II acts need further investigation. The beneficial actions of angiotensin receptor blockers in hypertension may be mediated in part via actions on the parasympathetic nervous system. We highlight important unknown questions about the interaction between the RAAS and the parasympathetic nervous system and conclude that this remains an important area where future research is needed. MDPI 2021-11-14 /pmc/articles/PMC8624735/ /pubmed/34830184 http://dx.doi.org/10.3390/ijms222212305 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Shanks, Julia
Ramchandra, Rohit
Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title_full Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title_fullStr Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title_full_unstemmed Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title_short Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
title_sort angiotensin ii and the cardiac parasympathetic nervous system in hypertension
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624735/
https://www.ncbi.nlm.nih.gov/pubmed/34830184
http://dx.doi.org/10.3390/ijms222212305
work_keys_str_mv AT shanksjulia angiotensiniiandthecardiacparasympatheticnervoussysteminhypertension
AT ramchandrarohit angiotensiniiandthecardiacparasympatheticnervoussysteminhypertension